Glucotrack (GCTK) Cash & Current Investments (2010 - 2025)
Glucotrack (GCTK) recorded quarterly Cash & Current Investments of $7.4 million in Q4 2025, down 18.87% on a QoQ basis from $9.1 million in Q1 2025, and up 31.44% year-over-year from $5.6 million in Q4 2024.
Glucotrack (GCTK) Cash & Current Investments (2010 - 2025) Analysis & Trends
Glucotrack has disclosed Cash & Current Investments across 16 years of filings, most recently posting $7.4 million for Q4 2025.
- Quarterly Cash & Current Investments rose 31.44% year-over-year to $7.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.4 million (up 31.44% YoY) and the FY2025 annual result came in at $7.4 million, up 31.44% from the prior year.
- Cash & Current Investments slipped to $7.4 million in Q4 2025, from $9.1 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $9.1 million in Q1 2025 and troughed at $159000.0 in Q2 2024.
- A 5-year average of $5.0 million and a median of $5.2 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments sank 98.19% — and 2025, when it surged 507.88%.
- Tracing GCTK's Cash & Current Investments over 5 years: stood at $6.1 million in 2021, then slumped by 61.86% to $2.3 million in 2022, then soared by 94.29% to $4.5 million in 2023, then increased by 25.04% to $5.6 million in 2024, then jumped by 31.44% to $7.4 million in 2025.
- Business Quant data shows GCTK's Cash & Current Investments at $7.4 million in Q4 2025, $9.1 million in Q1 2025, and $5.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 7.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.38 Mn |
| Mar 31, 2025 | 9.10 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Sep 30, 2024 | 346,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 4.49 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 8.77 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 3.24 Mn |
| Jun 30, 2022 | 3.85 Mn |
| Mar 31, 2022 | 4.79 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Sep 30, 2021 | 7.00 Mn |
| Jun 30, 2021 | 7.89 Mn |
| Mar 31, 2021 | 8.89 Mn |
| Dec 31, 2020 | 9.82 Mn |
| Sep 30, 2020 | 10.71 Mn |